The National Pharmaceutical Pricing Authority (NPPA) on March 05, 2025, issued a notification regarding fixation of the retail price of Sitagliptin Phosphate Monohydrate IP Eq. to Sitagliptin 100 mg + Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Synokem Pharmaceuticals Ltd. (Manufacturer) and M/s Blue Cross Laboratories Pvt. Ltd. (Marketer).
The following has been stated: -
•For each film-coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP Eq. to Sitagliptin 100 mg + Dapagliflozin Propanediol USP Eq. to Dapagliflozin 10 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Synokem Pharmaceuticals Ltd. (Manufacturer) and M/s Blue Cross Laboratories Pvt. Ltd. (Marketer) the retail price is 18.91 (Rs).
The detailed notification is given in the document below.
